R
Robert G Stirling
Researcher at Monash University
Publications - 110
Citations - 3696
Robert G Stirling is an academic researcher from Monash University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 30, co-authored 98 publications receiving 3235 citations. Previous affiliations of Robert G Stirling include Royal Perth Hospital & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
SMART-COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community-Acquired Pneumonia
Patrick G. P. Charles,Rory Wolfe,Michael Whitby,Michael J. Fine,Andrew Fuller,Robert G Stirling,Alistair Alexander Wright,Julio A. Ramirez,Keryn J. Christiansen,Grant W. Waterer,Robert J Pierce,John G. Armstrong,Tony M. Korman,Peter Holmes,Scott D Obrosky,Paula Peyrani,Barbara Johnson,Michelle Hooy,M Lindsay Liindsay Grayson,M Lindsay Liindsay Grayson +19 more
TL;DR: SMART-COP is a simple, practical clinical tool for accurately predicting the need for IRVS that is likely to assist clinicians in determining CAP severity.
Journal ArticleDOI
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
Allen P. Kaplan,Dennis K. Ledford,Mark Ashby,Janice Canvin,James L. Zazzali,Edward Conner,Joachim Veith,Nikhil Kamath,Petra Staubach,Thilo Jakob,Robert G Stirling,Piotr Kuna,William E. Berger,Marcus Maurer,Karin Rosén +14 more
TL;DR: In this paper, the authors evaluated the safety and efficacy of 24 weeks of treatment with omalizumab in patients with persistent chronic idiopathic urticaria/chronic spontaneous urticria (CIU/CSU) despite treatment with H 1 -antihistamines at up to 4 times the approved dose plus H 2 -antiHistamines, leukotriene receptor antagonists, or both.
Iconographies supplémentaires de l'article : Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
Allen P. Kaplan,Dennis K. Ledford,Mark Ashby,Janice Canvin,James L. Zazzali,Edward Conner,Joachim Veith,Nikhil Kamath,Petra Staubach,Thilo Jakob,Robert G Stirling,Piotr Kuna,William E. Berger,Marcus Maurer,Karin Rosén +14 more
TL;DR: In this paper, the authors evaluated the safety and efficacy of 24 weeks of treatment with omalizumab in patients with persistent chronic idiopathic urticaria/chronic spontaneous urticria (CIU/CSU) despite treatment with H1-antihistamines, leukotriene receptor antagonists, or both.
Journal ArticleDOI
The Etiology of Community-Acquired Pneumonia in Australia: Why Penicillin plus Doxycycline or a Macrolide Is the Most Appropriate Therapy
Patrick G. P. Charles,Michael Whitby,Andrew Fuller,Robert G Stirling,Alistair Alexander Wright,Tony M. Korman,Peter Holmes,Keryn J. Christiansen,Grant W. Waterer,Robert J Pierce,Barrie C. Mayall,John G. Armstrong,Michael G. Catton,Graeme R. Nimmo,Graeme R. Nimmo,Barbara Johnson,Michelle Hooy,M. L. Grayson,M. L. Grayson +18 more
TL;DR: The vast majority of patients with CAP can be treated successfully with narrow-spectrum beta-lactam treatment, such as penicillin combined with doxycycline or a macrolide, and greater use of such therapy could potentially reduce the emergence of antibiotic resistance among common bacterial pathogens.
Journal ArticleDOI
Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids
Robert G Stirling,S A Kharitonov,D Campbell,Douglas S. Robinson,Stephen R. Durham,Kian Fan Chung,P. J. Barnes +6 more
TL;DR: Exhaled NO may serve as a useful complement to lung function and symptomatology in the assessment of patients with chronic severe asthma, and in the control and rationalisation of steroid therapy in these patients.